Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
GALT on Nasdaq
Kevin D. Freeman - trading volume in the past year for Galectin Therapeutics Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
80K |
$65.1K |
$0.81 |
Dec 24, 2024 |
By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC |
|
|
| Common Stock |
44.8K |
$36.4K |
$0.81 |
Dec 24, 2024 |
Direct |
|
|
| Common Stock |
18.1K |
$14.7K |
$0.81 |
Dec 24, 2024 |
IRA |
|
|
| Stock Option (right to buy) |
60K |
|
|
Jan 23, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.